登輝(01692.HK)續彈逾55% 全年多賺六成勝預期兼上市不足半年已派息10.6仙
登輝控股(01692.HK)全年多賺六成高於盈喜預測至少五成,該股承昨天由上市低位逆彈16%勢,今早一舉重越四條移動平均線(0.63-0.7元),最高見0.92元,現造0.84元,急漲55.6%,一向薄弱成交急增至1,544萬股,涉資1,225萬元。
登輝是一間先進產品發展商、工業設計者及各種電熱家用電器的製造商和供應商。股份去年10月下旬才以每股1.3元上市,掛牌後股價持續「潛水」,高低見1.21元/0.43元。該公司昨天收市公布,截至去年底止全年純利按年增約60%,達6,081萬元,每股盈利19.07仙,末期股息10.6仙。期內,總收益按年增近37%至5.1億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.